Cover Image
市場調查報告書

體外受精 (IVF)的全球市場:週期類別 (新鮮,解凍,精卵捐贈IVF週期) 、各終端用戶 (不孕診所,醫院,外科中心,臨床研究機關) - 市場機會分析及產業預測

In Vitro Fertilization (IVF) Market by Cycle Type (Fresh, Thawed IVF and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centres and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

出版商 Allied Market Research 商品編碼 370260
出版日期 內容資訊 英文 414 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
體外受精 (IVF)的全球市場:週期類別 (新鮮,解凍,精卵捐贈IVF週期) 、各終端用戶 (不孕診所,醫院,外科中心,臨床研究機關) - 市場機會分析及產業預測 In Vitro Fertilization (IVF) Market by Cycle Type (Fresh, Thawed IVF and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centres and Clinical Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
出版日期: 2016年08月01日 內容資訊: 英文 414 Pages
簡介

預測全球體外受精 (IVF) 市場將由2015年90億1,500萬美金,到2022年前以年複合成長率10.2%擴大,達到177億1,400萬美元的收益。妊娠率低和妊娠期的延遲,生活習慣的變化,妊娠障礙等帶動市場成長。

本報告提供全球體外受精 (IVF) 市場相關調查,彙整市場上週期類別,各終端用戶趨勢與各地區趨勢,2014∼2022年的預測,及加入此市場的主要企業簡介等資料。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 各國IVF價格趨勢
  • 各國IVF週期
  • 各終端用戶市場
  • 週期類別市場
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 主要調查結果

第4章 北美市場

  • 北美的IVF市場
    • 不孕診所數
    • 各終端用戶市場
    • 週期類別市場
    • 促進要素
    • 阻礙要素
    • 法律規章的課題,法規化,權限
    • 保險給付方案
    • 企業簡介
  • 加拿大的IVF市場
  • 墨西哥的IVF市場

第5章歐洲的IVF市場

  • 德國市場
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 丹麥
  • 俄羅斯
  • 其他

第6章 亞太地區市場

  • 印度
  • 中國
  • 日本
  • 澳洲
  • 紐西蘭
  • 韓國
  • 泰國
  • 其他

第7章 南美·中東·非洲市場

  • 南美
  • 中東
  • 非洲

圖表

目錄
Product Code: LI 16678

Cover Image In vitro fertilization (IVF) is the process of artificial fertilization which happens outside the women's body. The egg of the women is surgical removed and are fertilized by a sperm in a laboratory. In vitro fertilization is mainly used by women having a problem in conceiving. However, IVF does not always result in pregnancy and success rate varies from individual to individual. IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry. The market is poised to witness a remarkable growth, primarily due to the related technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures.

The world IVF market accounted for $9,015 million in 2015 and is projected to garner revenues worth $17,714 million by 2022, registering a CAGR of 10.2% over the forecast period. The growth of the market is attributed to the reduced conceiving rates, delayed pregnancy, changing lifestyle conditions and fertility disorders are the major factors that drive the market growth. Other factors such as favourable reimbursement scenario and delayed parenthood opted by couples due to professional and financial constraints will also help in the growth of the market. On the other hand, barriers such as ethical concerns in particular countries with respect to IVF, high cost of the IVF procedures followed by low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.

Rising initiatives towards commercialization of cost-efficient treatments and emerging medical tourism, mainly in developing nations would offer lucrative growth opportunities for IVF service providers in future. Further, the growing clinical research initiatives for the development of novel IVF technologies would provide a platform for growth of the global IVF market.

The world IVF market is segmented on the basis of cycle type, end users and geography. Based on cycle types, the market is segmented into fresh cycle (non-donor), thawed IVF cycle (non-donor) and donor egg IVF cycles. Fresh cycle (non-donor) is both the highest revenue generating segment as well as the highest growing segment as it is the most commonly adopted method in a IVF process due to high success rate. Similarly, by end users, the market is further segmented into fertility clinics, hospitals, surgical centers and clinical research institutes. In terms of geography, the market is segmented into North America, Europe, Asia-Pacific (APAC) and Latin America, Middle East and Africa (LAMEA).

The Europe IVF market is the leading region in terms of revenue, whereas Asia Pacific is the fastest growing region, owing to growing demand for IVF processes. In terms of number of IVF cycles performed, the Asia-Pacific region dominates the global IVF market. Asia Pacific IVF market is set to grow at a promising CAGR of 13.3% from 2016 to 2022, due to factors such as wide availability of IVF clinics, high IVF success rates and the rising trend of fertility tourism. In Asia-Pacific region, Japan is the leading country accounting for majority of the market share and is expected to maintain its position throughout the analysis period.

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides an in-depth analysis of the IVF market across major countries with a cross sectional analysis of the number of IVF cycles performed, and total revenue generated during the forecast period
  • The report helps in understanding the strategies adopted by various IVF clinics and hospitals, in order to gain a higher market share in the global IVF market
  • Region-wise and country-wise share in the global IVF market is comprehensively analyzed in the report
  • The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2014-2022, in terms of value and volume
  • The study provides an in-depth analysis of the world IVF Services market with current trends and future estimations to elucidate the imminent investment pockets.

KEY MARKET SEGMENTS:

Market by End Users

  • Fertility Clinics
  • Hospitals
  • Surgical centers
  • Clinical research institutes

Market, By Geography

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Russia
    • Others Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • New Zealand
    • Korea
    • Thailand
    • Others APAC
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Table of Contents

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Benefits
  • 1.3. Key Market Segments
  • 1.4. Research Methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: WORLD IN VITRO FERTILIZATION (IVF) MARKET OVERVIEW

  • 3.1. Market Definition and Scope
  • 3.2. IVF Pricing Trends, By Country
  • 3.3. IVF Cycles, By Country
  • 3.4. Global IVF Market, by End User
    • 3.4.1. Fertility Clinics
    • 3.4.2. Hospitals
    • 3.4.3. Surgical Centers
    • 3.4.4. Clinical Research Institutes
  • 3.5. Global IVF Market by Cycle Type
    • 3.5.1. Fresh IVF Cycles (Non-donor)
    • 3.5.2. Thawed IVF Cycles (Non-donor)
    • 3.5.3. Donor Egg IVF Cycles
  • 3.6. Market Dynamics
    • 3.6.1. Drivers
      • 3.6.1.1. Delayed pregnancy
      • 3.6.1.2. Rise in global infertility rates
      • 3.6.1.3. Emergence of new fertility tourism destinations
    • 3.6.2. Restraints
      • 3.6.2.1. High Cost involved in treatment
      • 3.6.2.2. Low level of awareness in developing economies
      • 3.6.2.3. Inadequate reimbursements policies for IVF treatments
      • 3.6.2.4. Ethical Considerations
    • 3.6.3. Opportunities
      • 3.6.3.1. relaxation of legal considerations on ivf treatments
      • 3.6.3.2. New technology development and treatment options
      • 3.6.3.3. Three parent IVF
  • 3.7. Key Findings

CHAPTER 4: NORTH AMERICAN IVF MARKET

  • 4.1. U.S.: IVF Market, (Revenue and Number of Cycles)
    • 4.1.1. Number of Infertility Clinics, 2015
    • 4.1.2. U.S. IVF Market, by End Users
      • 4.1.2.1. Fertility clinics
      • 4.1.2.2. Hospitals
      • 4.1.2.3. Surgical centers
      • 4.1.2.4. Clinical research institutes
    • 4.1.3. U.S. IVF Market, by Cycle Type
      • 4.1.3.1. Fresh IVF cycles (non-donor)
      • 4.1.3.2. Thawed IVF cycles (non-donor)
      • 4.1.3.3. Donor egg IVF cycles
    • 4.1.4. Drivers
      • 4.1.4.1. Increasing popularity of IVF in the U.S.
      • 4.1.4.2. Increased rate of infertility and practices of embryo banking cycles
    • 4.1.5. Restraints
      • 4.1.5.1. High cost of IVF treatments in the U.S.
      • 4.1.5.2. Restrictions on three-parent IVF treatments
      • 4.1.5.3. Scattered Reimbursements
    • 4.1.6. Regulatory Issues, Legislations, and Authorities
    • 4.1.7. Insurance Reimbursement Scenario
    • 4.1.8. Company Profile
      • 4.1.8.1. Fertility and Gynecology Center Monterey Bay IVF
      • 4.1.8.2. Conceptions Reproductive Associates
      • 4.1.8.3. Servy Massey Fertility Institute
      • 4.1.8.4. Sher Institute for Reproductive Medicine (SIRM)
      • 4.1.8.5. Cardone Reproductive Medicine & Infertility
      • 4.1.8.6. Fertility Center of San Antonio
      • 4.1.8.7. Houston Fertility Center
      • 4.1.8.8. New hope fertility center
      • 4.1.8.9. Reproductive Medicine Associates Of New Jersey
  • 4.2. Canada IVF Market (Revenue and Number of Cycles)
    • 4.2.1. Number of Infertility Centers
    • 4.2.2. Canadian IVF Market, by End User
      • 4.2.2.1. Fertility clinics
      • 4.2.2.2. Hospitals
      • 4.2.2.3. Surgical centers
      • 4.2.2.4. Clinical research institutes
    • 4.2.3. Canadian IVF Market, By Cycle Type
      • 4.2.3.1. Fresh IVF cycles (non-donor)
      • 4.2.3.2. Thawed IVF cycles (non-donor)
      • 4.2.3.3. Donor egg IVF cycles
    • 4.2.4. Market Dynamics
      • 4.2.4.1. Drivers
        • 4.2.4.1.1. COMMERCIALIZATION OF IVF BOOSTER IN CANADA
      • 4.2.4.2. Restraints
        • 4.2.4.2.1. HIGH COST OF IVF IN CANADA
    • 4.2.5. Regulatory Issues, Legislations and Authorities
    • 4.2.6. Insurance Reimbursement Scenario
    • 4.2.7. Company Profile
      • 4.2.7.1. Toronto Centre for Advanced Reproductive Technology Ltd.
      • 4.2.7.2. Fertility Treatment Center
      • 4.2.7.3. Montreal Fertility Center
  • 4.3. Mexican IVF Market (Revenue and Number of Cycles)
    • 4.3.1. Number of Infertility Centers
    • 4.3.2. Mexico IVF Market by End Users
      • 4.3.2.1. Fertility clinics
      • 4.3.2.2. Hospitals
      • 4.3.2.3. Surgical centers
      • 4.3.2.4. Clinical research institutes
    • 4.3.3. Mexico IVF market by cycle type
      • 4.3.3.1. Fresh IVF cycles (non-donor)
      • 4.3.3.2. Thawed IVF cycles (non-donor)
      • 4.3.3.3. Donor egg IVF cycles
    • 4.3.4. Market Dynamics
      • 4.3.4.1. Drivers
        • 4.3.4.1.1. FERTILITY TOURISM
        • 4.3.4.1.2. COMPARATIVELY LOW COST OF IVF
      • 4.3.4.2. Restraints
        • 4.3.4.2.1. LANGUAGE BARRIERS
    • 4.3.5. Regulatory Issues, Legislations, and Authorities
    • 4.3.6. Insurance Reimbursement Scenario
    • 4.3.7. Company Profile
      • 4.3.7.1. Liv Fertility Center In Puerto Vallarta
      • 4.3.7.2. BFC Biofertility Center

CHAPTER 5: EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)

  • 5.1. Germany IVF Market (Revenue and Number of Cycles)
    • 5.1.1. Number of infertility clinics in Germany
    • 5.1.2. Germany IVF Market by End User
      • 5.1.2.1. Fertility clinics
      • 5.1.2.2. Hospitals
      • 5.1.2.3. Surgical centers
      • 5.1.2.4. Clinical research institutes
    • 5.1.3. Germany IVF market by cycle type
      • 5.1.3.1. Fresh IVF cycles (non-donor)
      • 5.1.3.2. Thawed IVF cycles (non-donor)
    • 5.1.4. Market Dynamics
      • 5.1.4.1. Drivers
        • 5.1.4.1.1. SUBSIDIZING IVF TREATMENTS
        • 5.1.4.1.2. DELAYED MARRIAGES AND PARENTHOOD DECISIONS
      • 5.1.4.2. Restraints
  • 5.1.4.2.1. LIMITED ADOPTION OF IVF METHODS
    • 5.1.5. Regulatory Issues, Legislations and Authorities
    • 5.1.6. Insurance Reimbursement Scenario
    • 5.1.7. Company Profile
      • 5.1.7.1. Heidelberg University Hospital
      • 5.1.7.2. Klinikum Stuttgart
      • 5.1.7.3. DRK Kliniken Berlin
      • 5.1.7.4. University Medical Center Freiburg
  • 5.2. France IVF Market (Revenue and Number of Cycles)
    • 5.2.1. Number of infertility centers in France
    • 5.2.2. France IVF Market by End User
      • 5.2.2.1. Fertility clinics
      • 5.2.2.2. Hospitals
      • 5.2.2.3. Surgical centers
      • 5.2.2.4. Clinical research institutes
    • 5.2.3. France IVF market by cycle type
      • 5.2.3.1. Fresh IVF cycles (non-donor)
      • 5.2.3.2. Thawed IVF cycles (non-donor)
      • 5.2.3.3. Donor egg IVF cycles
    • 5.2.4. Market Dynamics
      • 5.2.4.1. Drivers
        • 5.2.4.1.1. RISING ADOPTION OF IVF BABIES AMONG SAME GENDER POPULATION
        • 5.2.4.1.2. LOWER RATES OF FERTILITY
      • 5.2.4.2. Restraints
        • 5.2.4.2.1. STRINGENT GOVERNMENT REGULATIONS
    • 5.2.5. Regulatory Issues, Legislations, and Authorities
    • 5.2.6. Insurance Reimbursement Scenario
    • 5.2.7. Company Profile
      • 5.2.7.1. Clinique de la Muette
      • 5.2.7.2. Hopital des metallurgists, hopital cochin
  • 5.3. UK IVF Market (Revenue and Number of Cycles)
    • 5.3.1. Number of infertility centers in UK
    • 5.3.2. UK IVF Market by End User
      • 5.3.2.1. Fertility clinics
      • 5.3.2.2. Hospitals
      • 5.3.2.3. Surgical centers
      • 5.3.2.4. Clinical research institutes
    • 5.3.3. UK IVF market by cycle type
      • 5.3.3.1. Fresh IVF cycles (non-donor)
      • 5.3.3.2. Thawed IVF cycles (non-donor)
      • 5.3.3.3. Donor egg IVF cycles
    • 5.3.4. Drivers
      • 5.3.4.1. Commercialization of three-parent IVF procedures
      • 5.3.4.2. Supportive Regulations
    • 5.3.5. Restraints
      • 5.3.5.1. Ethical Considerations
    • 5.3.6. Regulatory Issues, Legislations and Authorities
    • 5.3.7. Insurance Reimbursement Scenario
    • 5.3.8. Company Profile
      • 5.3.8.1. Lister Fertility Clinic
      • 5.3.8.2. The Bridge Center
      • 5.3.8.3. Chelsea and Westminster Hospital (Assisted Conception Unit)
  • 5.4. Italy IVF Market (Revenue and Number of Cycles)
    • 5.4.1. Italy IVF market by End users
      • 5.4.1.1. Fertility clinics
      • 5.4.1.2. Hospitals
      • 5.4.1.3. Surgical centers
      • 5.4.1.4. Clinical research institutes
    • 5.4.2. Italy IVF market by cycle type
      • 5.4.2.1. Fresh IVF cycles (non-donor)
      • 5.4.2.2. Thawed IVF cycles (non-donor)
    • 5.4.3. Market Dynamics
      • 5.4.3.1. Drivers
      • 5.4.3.2. Restraints
  • 5.4.3.2.1. BAN ON SURROGACY
    • 5.4.4. Regulatory issues, legislations and authorities
    • 5.4.5. Insurance Reimbursement Scenario
    • 5.4.6. Company Profile
      • 5.4.6.1. ARC-STER srl
      • 5.4.6.2. RAPRUI
      • 5.4.6.3. Centre for Reproductive Medicine-Napoli
  • 5.5. Spain IVF Market (Revenue and Number of Cycles)
    • 5.5.1. Spain IVF Market by End Users
      • 5.5.1.1. Fertility clinics
      • 5.5.1.2. Hospitals
      • 5.5.1.3. Surgical centers
      • 5.5.1.4. Clinical research institutes
    • 5.5.2. Spain IVF Market by Cycle Type
      • 5.5.2.1. Fresh IVF cycles (non-donor)
      • 5.5.2.2. Thawed IVF cycles (non-donor)
      • 5.5.2.3. Donor egg IVF cycles
    • 5.5.3. Market Dynamics
      • 5.5.3.1. Drivers
      • 5.5.3.1.1. INCREASE IN THE NUMBER OF FOREIGN PATIENTS
      • 5.5.3.2. Restraints
    • 5.5.4. Regulatory Issues, Legislations and Authorities
    • 5.5.5. Insurance Reimbursement Scenario
    • 5.5.6. Company Profiles
      • 5.5.6.1. IVF spain
      • 5.5.6.2. Clnica EUGIN Barcelona
  • 5.6. Denmark IVF Market (Revenue and Number Of Cycles)
    • 5.6.1. Denmark IVF Market by End Users
      • 5.6.1.1. Fertility clinics
      • 5.6.1.2. Hospitals
      • 5.6.1.3. Surgical centers
      • 5.6.1.4. Clinical research institutes
    • 5.6.2. Denmark IVF market by cycle type
      • 5.6.2.1. Fresh IVF cycles (non-donor)
      • 5.6.2.2. Thawed IVF cycles (non-donor)
      • 5.6.2.3. Donor egg IVF cycles
    • 5.6.3. Drivers
      • 5.6.3.1. Increase in disposable income
      • 5.6.3.2. Advances in IVF technology
    • 5.6.4. Restraints
    • 5.6.5. Regulatory Issues, Legislations and Authorities
    • 5.6.6. Insurance Reimbursement Scenario
    • 5.6.7. Company Profiles
      • 5.6.7.1. Copenhagen Fertility Center
      • 5.6.7.2. Storkklinik v/Nina Stork
      • 5.6.7.3. Vitanova
      • 5.6.7.4. trianglen fertility clinic
      • 5.6.7.5. Nordica - Denmark, Copenhagen
  • 5.7. Russia IVF Market (Revenue and Number of Cycles)
    • 5.7.1. Russia IVF Market by End Users
      • 5.7.1.1. Fertility clinics
      • 5.7.1.2. Hospitals
      • 5.7.1.3. Surgical centers
      • 5.7.1.4. Clinical research institutes
    • 5.7.2. Russia IVF market by cycle type
      • 5.7.2.1. Fresh IVF cycles (non-donor)
      • 5.7.2.2. Thawed IVF cycles (non-donor)
      • 5.7.2.3. Donor egg IVF cycles
    • 5.7.3. Drivers
      • 5.7.3.1. Rising popularity of fertility tourism
    • 5.7.4. Restraints
      • 5.7.4.1. Inadequate reimbursement policies
    • 5.7.5. Regulatory Issues, Legislations, and Authorities
    • 5.7.6. Insurance Reimbursement Scenario
    • 5.7.7. Company Profiles
      • 5.7.7.1. ava-peter clinic
      • 5.7.7.2. md medical group
      • 5.7.7.3. ivf russia (The International Centre of the Reproductive Medicines)
  • 5.8. Rest of Europe IVF Market (Revenue and Number of Cycles)
    • 5.8.1. Rest of Europe IVF Market by End User
      • 5.8.1.1. Fertility clinics
      • 5.8.1.2. Hospitals
      • 5.8.1.3. Surgical centers
      • 5.8.1.4. Clinical research institutes
    • 5.8.2. Drivers
      • 5.8.2.1. Wide availability of reimbursements
      • 5.8.2.2. Changes in Lifestyle
    • 5.8.3. Restraints
    • 5.8.4. Regulatory Issues, Legislations and Authorities
    • 5.8.5. Insurance Reimbursement Scenario
    • 5.8.6. Company Profiles
      • 5.8.6.1. Gynaecoloqisch Centrum
      • 5.8.6.2. centrum voor medische genetica
      • 5.8.6.3. Infertility-Vestliitto

CHAPTER 6: ASIA-PACIFIC IVF MARKET (REVENUE AND NUMBER OF CYCLES)

  • 6.1. India IVF Market (Revenue and Number of Cycles)
    • 6.1.1. India IVF Market by End Users
      • 6.1.1.1. Fertility clinics
      • 6.1.1.2. Hospitals
      • 6.1.1.3. Surgical centers
      • 6.1.1.4. Clinical research institutes
    • 6.1.2. India IVF market by cycle type
      • 6.1.2.1. Fresh IVF cycles (non-donor)
      • 6.1.2.2. Thawed IVF cycles (non-donor)
      • 6.1.2.3. Donor egg IVF cycles
    • 6.1.3. Market Dynamics
      • 6.1.3.1. Drivers
      • 6.1.3.2. Restraints
    • 6.1.4. Regulatory Issues, Legislations and Authorities
    • 6.1.5. Insurance Reimbursement Scenario
    • 6.1.6. Company Profile
      • 6.1.6.1. Bourn Hall Clinic
      • 6.1.6.2. Southend Fertility and IVF Centre
      • 6.1.6.3. Morpheus IVF Fertility Center
      • 6.1.6.4. Bloom Fertility Center
      • 6.1.6.5. Manipal Ankur
      • 6.1.6.6. Cloudnine
      • 6.1.6.7. Nova IVI Fertility
  • 6.2. China IVF Market (Revenue and Number of Cycles)
    • 6.2.1. China IVF Market by End User
      • 6.2.1.1. Fertility clinics
      • 6.2.1.2. Hospitals
      • 6.2.1.3. Surgical centers
      • 6.2.1.4. Clinical research institutes
    • 6.2.2. China IVF market by cycle type
      • 6.2.2.1. Fresh IVF cycles (non-donor)
      • 6.2.2.2. Thawed IVF cycles (non-donor)
      • 6.2.2.3. Donor egg IVF cycles
    • 6.2.3. Market Dynamics
      • 6.2.3.1. Drivers
        • 6.2.3.1.1. CHANGE IN LIFESTYLE
      • 6.2.3.2. Restraints
        • 6.2.3.2.1. ONE CHILD POLICY
    • 6.2.4. Regulatory Issues, Legislations and Authorities
    • 6.2.5. Insurance Reimbursement Scenario
    • 6.2.6. Company profile
      • 6.2.6.1. Reproductive and genetic Hospital Citic-Xiangya
      • 6.2.6.2. Shenyang Hospital
      • 6.2.6.3. Shandong Provincial Hospital
      • 6.2.6.4. Centre for Reproductive Medicine
  • 6.3. Japan IVF Market (Revenue and Number of Cycles)
    • 6.3.1. Japan IVF Market by End User
      • 6.3.1.1. Fertility clinics
      • 6.3.1.2. Hospitals
      • 6.3.1.3. Surgical centers
      • 6.3.1.4. Clinical research institutes
    • 6.3.2. Japan IVF Market by Cycle Type
      • 6.3.2.1. Fresh IVF cycles (non-donor)
      • 6.3.2.2. Thawed IVF cycles (non-donor)
    • 6.3.3. Market Dynamics
      • 6.3.3.1. Drivers
      • 6.3.3.2. Restraints
    • 6.3.4. Regulatory Issues, Legislations, and Authorities
    • 6.3.5. Insurance Reimbursement Scenario
    • 6.3.6. Company Profile
      • 6.3.6.1. EMD Serono, Inc.
      • 6.3.6.2. IVF NAMBA Clinic
      • 6.3.6.3. Iwaki Womens Clinic
      • 6.3.6.4. Sanno Hospital
  • 6.4. Australia IVF Market (Revenue and Number of Cycles)
    • 6.4.1. Australia IVF Market by End User
      • 6.4.1.1. Fertility clinics
      • 6.4.1.2. Hospitals
      • 6.4.1.3. Surgical centers
      • 6.4.1.4. Clinical research institutes
    • 6.4.2. Australia IVF Market by Cycle Type
      • 6.4.2.1. Fresh IVF cycles (non-donor)
      • 6.4.2.2. Thawed IVF cycles (non-donor)
    • 6.4.3. Market Dynamics
      • 6.4.3.1. Drivers
      • 6.4.3.2. Restraints
        • 6.4.3.2.1. EMOTIONAL AND PHYSICAL STRESS
        • 6.4.3.2.2. NO GUARANTEE FOR THE SUCCESSFUL TREATMENTS
        • 6.4.3.2.3. SURPLUS EMBRYOS
    • 6.4.4. Regulatory Issues, Legislations, and Authorities
    • 6.4.5. Insurance Reimbursement Scenario
    • 6.4.6. Company Profile
      • 6.4.6.1. Genea Biomedx
      • 6.4.6.2. Thermo Fisher Scientific Inc.
      • 6.4.6.3. Virtus Health limited
      • 6.4.6.4. Monash IVF
      • 6.4.6.5. City Fertility center, brisbane
      • 6.4.6.6. Flinders Fertility clinic
  • 6.5. New Zealand IVF Market (Revenue and Number of Cycles)
    • 6.5.1. New Zealand IVF Market by End User
      • 6.5.1.1. Fertility clinics
      • 6.5.1.2. Hospitals
      • 6.5.1.3. Surgical centers
      • 6.5.1.4. Clinical research institutes
    • 6.5.2. New Zealand IVF Market by Cycle Type
      • 6.5.2.1. Fresh IVF cycles (non-donor)
      • 6.5.2.2. Thawed IVF cycles (non-donor)
      • 6.5.2.3. Donor egg IVF cycles
    • 6.5.3. Market Dynamics
      • 6.5.3.1. Drivers
      • 6.5.3.2. Restraints
    • 6.5.4. Regulatory Issues, Legislations, and Authorities
    • 6.5.5. Insurance Reimbursement Scenario
    • 6.5.6. Company Profiles
      • 6.5.6.1. Fertility Associates
      • 6.5.6.2. Fertility Plus
      • 6.5.6.3. Repromed
  • 6.6. Korea IVF Market (Revenue and Number of Cycles)
    • 6.6.1. Korea IVF Market by End User
      • 6.6.1.1. Fertility clinics
      • 6.6.1.2. Hospitals
      • 6.6.1.3. Surgical centers
      • 6.6.1.4. Clinical research institutes
    • 6.6.2. Korea IVF market by cycle type
      • 6.6.2.1. Fresh IVF cycles (non-donor)
      • 6.6.2.2. Thawed IVF cycles (non-donor)
      • 6.6.2.3. Donor egg IVF cycles
    • 6.6.3. Market Dynamics
      • 6.6.3.1. Drivers
      • 6.6.3.2. Restraints
    • 6.6.4. Regulatory Issues, Legislations, and Authorities
    • 6.6.5. Insurance Reimbursement Scenario
    • 6.6.6. Company Profiles
      • 6.6.6.1. Cha General Hospital
      • 6.6.6.2. MARIA Fertility Hospital
  • 6.7. Thailand IVF Market (Revenue and number of Cycles)
    • 6.7.1. Thailand IVF Market by End User
      • 6.7.1.1. Fertility clinics
      • 6.7.1.2. Hospitals
      • 6.7.1.3. Surgical centers
      • 6.7.1.4. Clinical research institutes
    • 6.7.2. Thailand IVF Market by Cycle Type
      • 6.7.2.1. Fresh IVF cycles (non-donor)
      • 6.7.2.2. Thawed IVF cycles (non-donor)
      • 6.7.2.3. Donor egg IVF cycles
    • 6.7.3. Market Dynamics
      • 6.7.3.1. Drivers
        • 6.7.3.1.1. GOVERNMENT INITIATIVES
        • 6.7.3.1.2. ECONOMIC CONSIDERATIONS
        • 6.7.3.1.3. BOOST IN MEDICAL TOURISM
      • 6.7.3.2. Restraints
        • 6.7.3.2.1. COMPARATIVELY LOW SUCCESS RATE
        • 6.7.3.2.2. ETHICAL ISSUES IN ALLOWING GENDER SELECTION
    • 6.7.4. Regulatory Issues, Legislations, and Authorities
    • 6.7.5. Insurance Reimbursement Scenario
    • 6.7.6. Company Profiles
      • 6.7.6.1. Bangkok Fertility Center
      • 6.7.6.2. Siriraj Hospital
      • 6.7.6.3. Ramathibodi Hospital
      • 6.7.6.4. Perfect Woman Institute
      • 6.7.6.5. Jetanin Institute for Assisted Reproduction
  • 6.8. Rest of Asia-Pacific IVF Market (Revenue and Number of Cycles)
    • 6.8.1. Rest of Asia-Pacific IVF Market by End User
      • 6.8.1.1. Fertility clinics
      • 6.8.1.2. Hospitals
      • 6.8.1.3. Surgical centers
      • 6.8.1.4. Clinical research institutes
    • 6.8.2. Drivers
      • 6.8.2.1. Increase in disposable income
      • 6.8.2.2. Advances in IVF technology
      • 6.8.2.3. Decline in fertility rate
    • 6.8.3. Restraints
      • 6.8.3.1. Physical and emotional impact due to low success rate
    • 6.8.4. Regulatory Issues, Legislations, and Authorities
    • 6.8.5. Insurance Reimbursement Scenario
    • 6.8.6. Company Profiles
      • 6.8.6.1. Fertility Centre, Siloam Hospitals Surabana
      • 6.8.6.2. CRM-MIA-Philippines
      • 6.8.6.3. IVFAS

CHAPTER 7: LAMEA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

  • 7.1. Latin America IVF Market (Revenue and Number of Cycles)
    • 7.1.1. Number of Infertility Centers
    • 7.1.2. Latin America IVF Market by End User
      • 7.1.2.1. Fertility clinics
      • 7.1.2.2. Hospitals
      • 7.1.2.3. Surgical centers
      • 7.1.2.4. Clinical research institutes
    • 7.1.3. Latin America IVF market by cycle type
      • 7.1.3.1. Fresh IVF cycles (non-donor)
      • 7.1.3.2. Thawed IVF cycles (non-donor)
      • 7.1.3.3. Donor egg IVF cycles
    • 7.1.4. Drivers
      • 7.1.4.1. Rising Medical Tourism in Latin America
      • 7.1.4.2. Permission for IVF treatments in Costa Rica
    • 7.1.5. Restraints
      • 7.1.5.1. High infant mortality rates in Brazil
    • 7.1.6. Regulatory Issues, Legislations, and Authorities
    • 7.1.7. Insurance Reimbursement Scenario
    • 7.1.8. Profiles of Major Players
      • 7.1.8.1. Clinica Anglo Americana
      • 7.1.8.2. IVF Panama Centro De Reproduccion
      • 7.1.8.3. Insemer
      • 7.1.8.4. Almater Hospital
      • 7.1.8.5. San Fernando Hospital
  • 7.2. Middle East IVF Market (Revenue and Number of Cycles)
    • 7.2.1. Number of Infertility Centers
    • 7.2.2. Middle East IVF Market by End User
      • 7.2.2.1. Fertility clinics
      • 7.2.2.2. Hospitals
      • 7.2.2.3. Surgical centers
      • 7.2.2.4. Clinical research institutes
    • 7.2.3. Middle East IVF Market by Cycle Type
      • 7.2.3.1. Fresh IVF cycles (non-donor)
      • 7.2.3.2. Thawed IVF cycles (non-donor)
      • 7.2.3.3. Donor egg IVF cycles
    • 7.2.4. Market Dynamics
      • 7.2.4.1. Drivers
        • 7.2.4.1.1. HIGH-TECH CULTURE
        • 7.2.4.1.2. AVAILABILITY OF REIMBURSEMENTS
      • 7.2.4.2. Restraints
        • 7.2.4.2.1. STRINGENT GOVERNMENT REGULATIONS
    • 7.2.5. Regulatory Issues, Legislations, and Authorities
    • 7.2.6. Insurance Reimbursement Scenario
    • 7.2.7. Company Profile
      • 7.2.7.1. Cyprus IVF Centre
      • 7.2.7.2. Al Bushra Medical Specialty Complex
      • 7.2.7.3. Reproductive Medicine Unit at Corniche Hospital (Corniche Fertility center)
      • 7.2.7.4. Trakya University Hospital ART Center
  • 7.3. Africa IVF Market (Revenue and Number of Cycles)
    • 7.3.1. Number of Infertility Centers
    • 7.3.2. Africa IVF Market by End User
      • 7.3.2.1. Fertility clinics
      • 7.3.2.2. Hospitals
      • 7.3.2.3. Surgical centers
      • 7.3.2.4. Clinical research institutes
    • 7.3.3. Africa IVF Market by Cycle Type
      • 7.3.3.1. Fresh IVF cycles (non-donor)
      • 7.3.3.2. Thawed IVF cycles (non-donor)
      • 7.3.3.3. Donor egg IVF cycles
    • 7.3.4. Drivers
      • 7.3.4.1. Low costs of IVF treatment
      • 7.3.4.2. Rising Fertility Tourism in South Africa
    • 7.3.5. Restraints
      • 7.3.5.1. Susceptibility toward fibroids
    • 7.3.6. Regulatory Issues, Legislations, and Authorities
    • 7.3.7. Insurance Reimbursement Scenario
    • 7.3.8. Company Profile
      • 7.3.8.1. Lifesure Fertility & Gynaecology Centre
      • 7.3.8.2. Bethany Women and Family Hospital
      • 7.3.8.3. BioART Fertility Centre
      • 7.3.8.4. DEL International Hospital & Fertility Centre
      • 7.3.8.5. Gift ov life
      • 7.3.8.6. Durban Fertility Clinic
      • 7.3.8.7. Cape fertility clinic

List of Tables

  • TABLE 1: IVF PRICING TRENDS, BY COUNTRY, 2015
  • TABLE 2: GLOBAL IVF MARKET, BY COUNTRY, 20142022 (THOUSAND)
  • TABLE 3: GLOBAL IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 4: GLOBAL IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 5: GLOBAL IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 6: GLOBAL IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 7: IVF SUCCESS RATES BASED ON AGE
  • TABLE 8: NORTH AMERICAN IVF MARKET, BY COUNTRY, 20142022 (THOUSAND)
  • TABLE 9: NORTH AMERICAN IVF MARKET, BY COUNTRY, 20142022 ($MILLION)
  • TABLE 10: U.S. IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND AND $MILLION)
  • TABLE 11: NUMBER OF FERTILITY CLINICS IN U.S. (2015)
  • TABLE 12: U.S. IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 13: UNITED STATES IVF MARKET, BY END USERS, 2014 2022 ($MILLION)
  • TABLE 14: U.S. IVF MARKET BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 15: U.S. IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 16: FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEW
  • TABLE 17: SNAPSHOT OF FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY
  • TABLE 18: CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEW
  • TABLE 19: SNAPSHOT OF CONCEPTIONS REPRODUCTIVE ASSOCIATES
  • TABLE 20: SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
  • TABLE 21: SNAPSHOT OF SERVY MASSEY FERTILITY INSTITUTE
  • TABLE 22: SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM): BUSINESS OVERVIEW
  • TABLE 23: SNAPSHOT OF INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
  • TABLE 24: CARDONE REPRODUCTIVE MEDICINE & INFERTILITY: BUSINESS OVERVIEW
  • TABLE 25: SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE & INFERTILITY
  • TABLE 26: FERTILITY CENTER OF SAN ANTONIO: BUSINESS OVERVIEW
  • TABLE 27: SNAPSHOT OF FERTILITY CENTER OF SAN ANTONIO
  • TABLE 28: HOUSTON FERTILITY CENTER: BUSINESS OVERVIEW
  • TABLE 29: SNAPSHOT OF HOUSTON FERTILITY CENTER
  • TABLE 30: NEW HOPE FERTILITY CENTER BUSINESS OVERVIEW
  • TABLE 31: SNAPSHOT OF HOUSTON FERTILITY CENTER
  • TABLE 32: REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY BUSINESS OVERVIEW
  • TABLE 33: SNAPSHOT OF HOUSTON FERTILITY CENTER
  • TABLE 34: CANADIAN IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND AND $MILLION)
  • TABLE 35: CANADIAN IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 36: CANADIAN IVF MARKET BY END USERS, 20142022 ($MILLION)
  • TABLE 37: CANADIAN IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 38: CANADIAN IVF MARKET BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 39: BUSINESS OVERVIEW
  • TABLE 40: SNAPSHOT OF TORONTO CENTRE FOR ADVANCED REPRODUCTIVE TECHNOLOGY LTD.
  • TABLE 41: FERTILITY TREATMENT CENTER: BUSINESS OVERVIEW
  • TABLE 42: SNAPSHOT OF FERTILITY TREATMENT CENTER
  • TABLE 43: FERTILITY TREATMENT CENTER BUSINESS OVERVIEW
  • TABLE 44: SNAPSHOT OF FERTILITY TREATMENT CENTER
  • TABLE 45: MEXICAN IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND AND $MILLION)
  • TABLE 46: MEXICAN IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 47: MEXICAN IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 48: MEXICAN IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 49: MEXICAN IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 50: LIV FERTILITY CENTER IN PUERTO VALLARTA: BUSINESS OVERVIEW
  • TABLE 51: SNAPSHOT OF FERTILITY TREATMENT CENTER
  • TABLE 52: BIOFERTILITY CENTER IN GUDALAJARA: BUSINESS OVERVIEW
  • TABLE 53: SNAPSHOT OF FERTILITY TREATMENT CENTER
  • TABLE 54: EUROPE: IVF SERVICE MARKET, BY COUNTRY, 20142022 (THOUSAND)
  • TABLE 55: EUROPE: IVF MARKET, BY COUNTRY, 20142022 ($MILLION)
  • TABLE 56: GERMANY: IVF SERVICE MARKET, VOLUME & VALUE, 20142022 (THOUSAND & $MILLION)
  • TABLE 57: GERMANY: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 58: GERMANY: IVF MARKET BY END USER, 20142022 ($MILLION)
  • TABLE 59: GERMANY: IVF MARKET VALUE, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 60: GERMANY: IVF MARKET VOLUME, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 61: HEIDELBERG UNIVERSITY HOSPITAL BUSINESS OVERVIEW
  • TABLE 62: SNAPSHOT OF HEIDELBERG UNIVERSITY HOSPITAL
  • TABLE 63: KLINIKUM STUTTGART BUSINESS OVERVIEW
  • TABLE 64: COMPANY SNAPSHOT
  • TABLE 65: DRK KLINIKEN BERLIN BUSINESS OVERVIEW
  • TABLE 66: SNAPSHOT OF DRK KLINIKEN BERLIN
  • TABLE 67: UNIVERSITY MEDICAL CENTER FREIBURG BUSINESS OVERVIEW
  • TABLE 68: SNAPSHOT OF UNIVERSITY MEDICAL CENTER FREIBURG
  • TABLE 69: FRANCE: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 70: FRANCE: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 71: FRANCE: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 72: FRANCE: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 73: FRANCE: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 74: CLINIQUE DE LA MUETTE BUSINESS OVERVIEW
  • TABLE 75: SNAPSHOT OF CLINIQUE DE LA MUETTE
  • TABLE 76: HOPITAL DES METALLURGISTS, HOPITAL COCHIN BUSINESS OVERVIEW
  • TABLE 77: SNAPSHOT OF HOPITAL DES METALLURGISTS, HOPITAL COCHIN
  • TABLE 78: IVF CYCLES BY VARIOUS AGE GROUPS, UK, 2015
  • TABLE 79: PROPORTION OF IVF CYCLES USING FRESH & FROZEN EGGS, UK, 20102011
  • TABLE 80: IVF SUCCESS RATES IN UK (AS PER NHS), 2015
  • TABLE 81: REGIONAL IVF CLINICS AND TOTAL NUMBER OF WOMEN TREATED, UK, 2015
  • TABLE 82: UK IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 83: UK IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 84: UK IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 85: UK IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 86: UK IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 87: LISTER FERTILITY CLINIC BUSINESS OVERVIEW
  • TABLE 88: COMPANY SNAPSHOT
  • TABLE 89: THE BRIDGE CENTER BUSINESS OVERVIEW
  • TABLE 90: SNAPSHOT OF THE BRIDGE CENTER
  • TABLE 91: CHELSEA AND WESTMINSTER HOSPITAL BUSINESS OVERVIEW
  • TABLE 92: SNAPSHOT OF CHELSEA AND WESTMINSTER HOSPITAL
  • TABLE 93: ITALY: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 94: ITALY: IVF MARKET BY END USER, 20142022 ($MILLION)
  • TABLE 95: ITALY: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 96: ITALY: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 97: ITALY: IVF MARKET BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 98: SPAIN: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 99: SPAIN: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 100: SPAIN: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 101: SPAIN: IVF MARKET BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 102: SPAIN: IVF MARKET BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 103: DENMARK: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 104: DENMARK: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 105: DENMARK: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 106: DENMARK: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 107: DENMARK: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 108: RUSSIA: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 109: RUSSIA: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 110: RUSSIA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 111: RUSSIA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 112: RUSSIA: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 113: REST OF EUROPE: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 114: REST OF EUROPE: IVF MARKET REVENUE BY END USER, 20142022 ($MILLION)
  • TABLE 115: REST OF EUROPE: IVF CYCLES BY END USER, 20142022 (THOUSAND)
  • TABLE 116: ASIA-PACIFIC IVF MARKET, BY COUNTRY, 20142022 (THOUSAND)
  • TABLE 117: ASIA-PACIFIC: IVF MARKET, BY COUNTRY, 20142022 ($MILLION)
  • TABLE 118: INDIA: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 119: INDIA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 120: INDIA: IVF MARKET, BY END USERS, 20142022 ($MILLION)
  • TABLE 121: INDIA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 122: INDIA: IVF MARKET BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 123: BOURN HALL BUSINESS OVERVIEW
  • TABLE 124: SOUTHEND FERTILITY AND IVF CENTRE BUSINESS OVERVIEW
  • TABLE 125: MORPHEUS IVF FERTILITY CENTER BUSINESS OVERVIEW
  • TABLE 126: BLOOM FERTILITY CENTER BUSINESS OVERVIEW
  • TABLE 127: MANIPAL ANKUR BUSINESS OVERVIEW
  • TABLE 128: CLOUDNINE BUSINESS OVERVIEW
  • TABLE 129: NOVA IVI FERTILITY BUSINESS OVERVIEW
  • TABLE 130: CHINA: IVF MARKET, VOLUME & VALUE, 20142022 (THOUSAND $MILLION)
  • TABLE 131: CHINA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 132: CHINA: IVF MARKET BY END USER, 20142022 ($MILLION)
  • TABLE 133: CHINA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 134: CHINA: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 135: REPRODUCTIVE AND GENETIC HOSPITAL CITIC-XIANGYA, BUSINESS OVERVIEW
  • TABLE 136: SHENYANG HOSPITAL BUSINESS OVERVIE
  • TABLE 137: SHANDONG PROVINCIAL HOSPITAL BUSINESS OVERVIEW
  • TABLE 138: CENTRE FOR REPRODUCTIVE MEDICINE, BUSINESS OVERVIEW
  • TABLE 139: JAPAN: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 140: JAPAN: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 141: JAPAN: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 142: JAPAN: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 143: JAPAN: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 144: EMD SERONO INC. BUSINESS OVERVIEW
  • TABLE 145: SNAPSHOT OF EMD SERONO INC.
  • TABLE 146: IVF NAMBA CLINIC BUSINESS OVERVIEW
  • TABLE 147: IWAKI WOMENS CLINIC BUSINESS OVERVIEW
  • TABLE 148: SANNO HOSPITAL BUSINESS OVERVIEW
  • TABLE 149: AUSTRALIA: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 150: AUSTRALIA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 151: AUSTRALIA: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 152: AUSTRALIA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 153: AUSTRALIA: IVF MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
  • TABLE 154: GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEW
  • TABLE 155: SNAPSHOT OF GENEA BIOMEDX TECHNOLOGIES
  • TABLE 156: THERMO FISHER SCIENTIFIC INC. BUSINESS OVERVIEW
  • TABLE 157: SNAPSHOT OF THERMO FISHER SCIENTIFIC INC.
  • TABLE 158: VIRTUS HEALTH BUSINESS OVERVIEW
  • TABLE 159: MONASH IVF BUSINESS OVERVIEW
  • TABLE 160: CITY FERTILITY BUSINESS OVERVIEW
  • TABLE 161: FLINDERS FERTILITY BUSINESS OVERVIEW
  • TABLE 162: NEW ZEALAND: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 163: NEW ZEALAND: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 164: NEW ZEALAND: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 165: NEW ZEALAND: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 166: NEW ZEALAND: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 167: KOREA: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 168: KOREA: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 169: KOREA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 170: KOREA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 171: KOREA: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 172: THAILAND: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 173: THAILAND: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 174: THAILAND: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 175: THAILAND: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 176: THAILAND: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 177: REST OF ASIA-PACIFIC: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 178: REST OF ASIA-PACIFIC IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 179: REST OF ASIA-PACIFIC: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 180: LAMEA IVF MARKET, BY COUNTRY, 20142022 (THOUSAND)
  • TABLE 181: LAMEA IVF MARKET, BY COUNTRY, 20142022 ($MILLION)
  • TABLE 182: LATIN AMERICA: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 183: LATIN AMERICA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 184: LATIN AMERICA: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 185: LATIN AMERICA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 186: LATIN AMERICA: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 187: CLINICA ANGLO AMERICANA BUSINESS OVERVIEW
  • TABLE 188: SNAPSHOT OF CLINICA ANGLO AMERICANA
  • TABLE 189: IVF PANAMA CENTRO DE REPRODUCCION PUNTA PACIFICA BUSINESS OVERVIEW
  • TABLE 190: SNAPSHOT OF IVF PANAMA CENTRO DE REPRODUCCION PUNTA PACIFICA
  • TABLE 191: INSAMER BUSINESS OVERVIEW
  • TABLE 192: COMPANY SNAPSHOT
  • TABLE 193: ALMATER HOSPITAL BUSINESS OVERVIEW
  • TABLE 194: COMPANY SNAPSHOT
  • TABLE 195: SAN FERNANDO HOSPITAL BUSINESS OVERVIEW
  • TABLE 196: COMPANY SNAPSHOT
  • TABLE 197: MIDDLE EAST: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 198: MIDDLE EAST: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 199: MIDDLE EAST: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 200: MIDDLE EAST: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 201: MIDDLE EAST: IVF MARKET BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 202: CYPRUS IVF CENTRE BUSINESS OVERVIEW
  • TABLE 203: COMPANY SNAPSHOT
  • TABLE 204: AL BUSHRA MEDICAL SPECIALTY COMPLEX BUSINESS OVERVIEW
  • TABLE 205: COMPANY OF AL BUSHRA MEDICAL SPECIALTY COMPLEX
  • TABLE 206: REPRODUCTIVE MEDICINE UNIT AT CORNICHE HOSPITAL BUSINESS OVERVIEW
  • TABLE 207: SNAPSHOT OF REPRODUCTIVE MEDICINE UNIT AT CORNICHE HOSPITAL
  • TABLE 208: TRAKYA UNIVERSITY HOSPITAL ART CENTER BUSINESS OVERVIEW
  • TABLE 209: SNAPSHOT OF TRAKYA UNIVERSITY HOSPITAL ART CENTER
  • TABLE 210: AFRICA: IVF MARKET, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • TABLE 211: AFRICA: IVF MARKET, BY END USER, 20142022 (THOUSAND)
  • TABLE 212: AFRICA: IVF MARKET, BY END USER, 20142022 ($MILLION)
  • TABLE 213: AFRICA: IVF MARKET, BY CYCLE TYPE, 20142022 ($MILLION)
  • TABLE 214: AFRICA: IVF MARKET, BY CYCLE TYPE, 20142022 (THOUSAND)
  • TABLE 215: LIFESURE FERTILITY & GYNAECOLOGY CENTRE BUSINESS OVERVIEW
  • TABLE 216: COMPANY SNAPSHOT
  • TABLE 217: BETHANY WOMEN AND FAMILY HOSPITAL BUSINESS OVERVIEW
  • TABLE 218: COMPANY SNAPSHOT
  • TABLE 219: BIOART FERTILITY CENTRE BUSINESS OVERVIEW
  • TABLE 220: COMPANY SNAPSHOT
  • TABLE 221: DEL INTERNATIONAL HOSPITAL & FERTILITY CENTRE BUSINESS OVERVIEW
  • TABLE 222: COMPANY SNAPSHOT
  • TABLE 223: GIFT OV LIFE BUSINESS OVERVIEW
  • TABLE 224: COMPANY SNAPSHOT
  • TABLE 225: DURBAN FERTILITY CLINIC BUSINESS OVERVIEW
  • TABLE 226: COMPANY SNAPSHOT
  • TABLE 227: CAPE FERTILITY CLINIC BUSINESS OVERVIEW
  • TABLE 228: COMPANY SNAPSHOT

List of Figures

  • FIG. 1: GLOBAL IVF MARKET, BY FERTILITY CLINICS, VOLUME, AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 2: WORLD IVF MARKET, BY HOSPITAL, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 3: WORLD IVF MARKET, BY SURGICAL CENTER, VOLUME AND VALUE, 2014-022, (THOUSAND, $MILLION)
  • FIG. 4: GLOBAL IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 5: WORLD IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 6: WORLD IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 7: WORLD IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 8: WORLD IVF MARKET, BY GEOGRAPHY, 20152022 ($MILLION)
  • FIG. 9: WORLD IVF MARKET, BY GEOGRAPHY, 20152022 (THOUSAND)
  • FIG. 10: U.S. IVF MARKET, BY FERTILITY CLINICS, VOLUME, AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 11: U.S. IVF MARKET, BY HOSPITAL, VOLUME AND, VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 12: U.S. IVF MARKET, BY SURGICAL CENTER, 20142022, VOLUME AND VALUE (THOUSAND, $MILLION)
  • FIG. 13: U.S. IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 14: U.S. IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 15: U.S. IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 16: U.S. IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 17: ART REGULATORY SCENARIO, U.S.
  • FIG. 18: CANADIAN IVF MARKET, BY FERTILITY CLINIC, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 19: CANADIAN IVF MARKET, BY HOSPITAL, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 20: CANADIAN IVF MARKET, BY SURGICAL CENTER, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 21: CANADIAN IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 22: CANADIAN IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 23: CANADIAN IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 24: CANADIAN IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 25: ART REGULATORY SCENARIO, CANADA
  • FIG. 26: MEXICAN IVF MARKET, BY FERTILITY CLINIC, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 27: MEXICAN IVF MARKET, BY HOSPITAL, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 28: MEXICAN IVF MARKET, BY SURGICAL CENTER, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 29: MEXICAN IVF MARKET, BY CLINICAL RESEARCH INSTITUTE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 30: MEXICAN IVF MARKET, BY FRESH IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 31: MEXICAN IVF MARKET, BY THAWED IVF CYCLE, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
  • FIG. 32: MEXICAN IVF MARKET, BY DONOR EGG IVF CYCLE, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 33: ART REGULATORY SCENARIO, MEXICO
  • FIG. 34: GERMANY: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 35: GERMANY: IVF MARKET, BY HOSPITAL, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 36: GERMANY: IVF MARKET, BY SURGICAL CENTER, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 37: GERMANY: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 38: GERMANY: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 39: GERMANY: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 40: REGULATORY SCENARIO, GERMANY
  • FIG. 41: FRANCE: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 42: FRANCE: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 43: FRANCE: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 44: FRANCE: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 45: FRANCE: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 46: FRANCE: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 47: FRANCE: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 48: REGULATORY SCENARIO, FRANCE
  • FIG. 49: UK IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 50: UK IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 51: UK IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 52: UK IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 53: UK IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 54: UK IVF MARKET, BY THAWED IVF CYCLE, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 55: UK IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 56: REGULATORY SCENARIO, UK
  • FIG. 57: ITALY: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 58: ITALY: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 59: ITALY: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 60: ITALY: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 61: ITALY: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 62: ITALY: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 63: SPAIN: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 64: SPAIN: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 65: SPAIN: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 66: SPAIN: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 67: SPAIN: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 68: SPAIN: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 69: SPAIN: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 70: DENMARK: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 71: DENMARK: IVF MARKET, BY HOSPITAL, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 72: DENMARK: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 73: DENMARK: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 74: DENMARK: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 75: DENMARK: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 76: DENMARK: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 77: RUSSIA: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 78: RUSSIA: IVF MARKET, BY HOSPITAL, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 79: RUSSIA: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 80: RUSSIA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 81: RUSSIA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 82: RUSSIA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 83: RUSSIA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 84: REST OF EUROPE: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 85: REST OF EUROPE: IVF MARKET, BY HOSPITAL, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 86: REST OF EUROPE: IVF MARKET, BY SURGICAL CENTER, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 87: REST OF EUROPE: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 88: INDIA: TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
  • FIG. 89: INDIA: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 90: INDIA: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 91: INDIA: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 92: INDIA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 93: INDIA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 94: INDIA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 95: INDIA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 96: CHINA FERTILITY RATE (CHILDREN BORN/WOMEN)
  • FIG. 97: CHINA: IVF MARKET, BY FERTILITY CLINICS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 98: CHINA: IVF MARKET, BY HOSPITALS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 99: CHINA: IVF MARKET, BY SURGICAL CENTERS, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 100: CHINA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 101: CHINA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 102: CHINA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 103: CHINA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME & VALUE, 20142022, (THOUSAND, $MILLION)
  • FIG. 104: JAPAN: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN)
  • FIG. 105: JAPAN: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 106: JAPAN: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 107: JAPAN: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 108: JAPAN: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 109: JAPAN: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 110: JAPAN: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 111: AUSTRALIA: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN)
  • FIG. 112: IVF SUCCESS RATE FOR AUSTRALIA
  • FIG. 113: AUSTRALIA: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 114: AUSTRALIA: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 115: AUSTRALIA: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 116: AUSTRALIA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 117: AUSTRALIA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 118: AUSTRALIA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 119: NEW ZEALAND: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN)
  • FIG. 120: NEW ZEALAND: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 121: NEW ZEALAND: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 122: NEW ZEALAND: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 123: NEW ZEALAND: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 124: NEW ZEALAND: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 125: NEW ZEALAND: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 126: NEW ZEALAND: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 127: KOREA: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN)
  • FIG. 128: KOREA: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 129: KOREA: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 130: KOREA: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
  • FIG. 131: KOREA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 132: KOREA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 133: KOREA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 134: KOREA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 135: THAILAND: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 136: THAILAND: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 137: THAILAND: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 138: THAILAND: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 139: THAILAND: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 140: THAILAND: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 141: THAILAND: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 142: REST OF ASIA-PACIFIC: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 143: REST OF ASIA-PACIFIC: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 144: REST OF ASIA-PACIFIC: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 145: REST OF ASIA-PACIFIC: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 146: LATIN AMERICA: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 147: LATIN AMERICA: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 148: LATIN AMERICA: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 149: LATIN AMERICA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 150: LATIN AMERICA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 151: LATIN AMERICA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 152: LATIN AMERICA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 153: LATIN AMERICA: ART REGULATORY SCENARIO,
  • FIG. 154: MIDDLE EAST: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 155: MIDDLE EAST: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 156: MIDDLE EAST: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 157: MIDDLE EAST: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 158: MIDDLE EAST: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 159: MIDDLE EAST: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 160: MIDDLE EAST: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 161: MIDDLE EAST: ART REGULATORY SCENARIO
  • FIG. 162: AFRICA: IVF MARKET, BY FERTILITY CLINICS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 163: AFRICA: IVF MARKET, BY HOSPITALS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 164: AFRICA: IVF MARKET, BY SURGICAL CENTERS, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 165: AFRICA: IVF MARKET, BY CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 166: AFRICA: IVF MARKET, BY FRESH IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 167: AFRICA: IVF MARKET, BY THAWED IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 168: AFRICA: IVF MARKET, BY DONOR EGG IVF CYCLES, VOLUME AND VALUE, 20142022 (THOUSAND, $MILLION)
  • FIG. 169: AFRICA: ART REGULATORY SCENARIO
Back to Top